Skip to main content
. 2013 May 31;2013(5):CD004525. doi: 10.1002/14651858.CD004525.pub2

43.19. Analysis.

43.19

Comparison 43 Adverse events within 12 months: etanercept vs. disease‐modifying anti‐rheumatic drug (DMARD), Outcome 19 Upper respiratory tract infection.